Pigmentary disorders, prevalence, impact on quality of life, social stigmatization: Results of the first large international survey

T. Passeron, L. Wei, A. Morita, C.L. Goh, A. Alexis, B. Dreno, H.Y. Kang, F. Ly, S. Puig, S. Schalka, J. Ocampo Candiani, A.L. Demessant, C. Le Floc'h, D. Kerob, J. Krutmann, H.W. Lim

  • 10min
  • Feb. 2024
  • Supported by
  • La Roche-Posay

INTRODUCTION & OBJECTIVES

Pigmentary disorders (PD) such as Melasma, Post-inflammatory Hyperpigmentation (PIH), Solar Lentigo, Peri-Orbital Hyperpigmentation (POH) and Axillary Hyperpigmentation (AH) are frequent dermatological conditions, but little is known on their real-world prevalence and impact. This fisrt worldwide survey evaluates the prevalence of PD and its impact on quality of life (QOL) and stigmatization.

IMCAS 2024 POSTER